We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ZNTL market cap is 215.93M. The company's latest EPS is USD -4.1000 and P/E is -0.74.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 40.56M | 0 | 0 |
| Operating Income | -57.77M | -88.89M | -24.77M | -65.15M | -51.43M |
| Net Income | -55.53M | -60.92M | 10.07M | -88.28M | -40.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -46.85M | -118.79M | -209.57M | -243.57M | -315.52M |
| Net Income | -45.66M | -117.84M | -158.73M | -236.81M | -292.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 585.72M | 551.69M | 557.48M | 491.68M | 450.66M |
| Total Liabilities | 103.82M | 114.3M | 98.71M | 109.1M | 96.33M |
| Total Equity | 481.9M | 437.39M | 458.77M | 382.58M | 354.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 87.48M | 365.56M | 454.51M | 539.31M | 551.69M |
| Total Liabilities | 19.06M | 32.18M | 90.03M | 105.29M | 114.3M |
| Total Equity | -73.29M | 333.38M | 364.48M | 434.02M | 437.39M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -167.22M | -207.82M | -51.97M | -87.11M | -131.16M |
| Investing | -2.4M | -44.46M | 61.55M | 96.04M | 144.28M |
| Financing | 237.3M | 237.3M | 7k | 16k | 108k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.14M | -86.83M | -154.09M | -163.75M | -207.82M |
| Investing | -352k | -284.83M | -18.12M | -114.18M | -44.46M |
| Financing | 81.83M | 360.44M | 178.52M | 261.04M | 237.3M |
| Market Cap | 215.93M |
| Price to Earnings Ratio | -0.74 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.7 |
| Price to Book Ratio | 0.49 |
| Dividend Yield | - |
| Shares Outstanding | 71.27M |
| Average Volume (1 week) | 1.36M |
| Average Volume (1 Month) | 1.17M |
| 52 Week Change | -79.64% |
| 52 Week High | 18.07 |
| 52 Week Low | 2.6612 |
| Spread (Intraday) | 0.55 (16.18%) |
| Company Name | Zentalis Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.zentalis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
